AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2016
May 17, 2016
31949_dirs_2016-05-17_83e5654e-3798-4340-8c5c-4f05100368f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-05-13
Reporting Person: VERNON W ANTHONY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-13 | Ordinary Shares | M | 249085 | $0.17 | Acquired | 249085 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-13 | Options to Buy Ordinary Shares | $0.17 | M | 249085 | Disposed | 2016-12-25 | Ordinary Shares (249085) | Direct |
Footnotes
F1: Fully vested and currently exercisable as of the date hereof.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3